Policy & Sector Insights
-
Nov 3, 2017
PBMI Report Shows Changes in Pharmacy Benefit Design to Meet Cost Challenges
PBMI
Although employers continue to cite managing drug cost trend as the number one goal, they are addressing this challenge head on by implementing significant changes in drug benefit design…View the Report. -
Nov 3, 2017
THE FLOW OF MONEY THROUGH THE PHARMACEUTICAL DISTRIBUTION SYSTEM
USC Schaeffer
US spending on prescription drugs has been growing rapidly, prompting calls for government intervention to slow the upward trend…View the Report. -
Nov 1, 2017
Senate takes aim at pharmacy benefit managers’ role in rising drug costs
Modern Medicine
Amid concerns about the escalating cost of prescription drugs, the Senate’s Health, Education, Labor, and Pensions (HELP) Committee held hearings this summer to frame the Senate’s efforts moving forward…Read More. -
Nov 1, 2017
Perverse Market Incentives Encourage High Prescription Drug Prices
Perverse Market
Pharmacy benefit managers (PBMs) are the under-discussed market participants who manage prescription drug insurance for the vast majority of Americans…Read More. -
Oct 30, 2017
Flurry Of Federal And State Probes Target Insulin Drugmakers And Pharma Middlemen
Kaiser Health News
Five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen, seeking answers about their business relationships and the soaring price of diabetes drugs…Read More. -
Oct 30, 2017
FTC, FDA To Probe Generic Competition, PBMs, Purchaser Consolidation
Inside Health Policy
An upcoming public workshop spearheaded by the Federal Trade Commission and FDA will delve into possible incentives for generic market entry, what can be done to address tactics used to stall generic competition, the role intermediaries play in drug pricing and how FTC can address these issues….Read More. -
Oct 26, 2017
63% of employers say PBMs not transparent about how they make money
Becker’s Hospital Review
Only 30 percent of respondents said they understand the details of their PBM contracts, and 40 percent said they understand their PBM’s performance guarantees…Read More. -
Oct 23, 2017
Cummings Investigates Reports That Plans, PBMs Favor Addictive Opioids Over Expensive, Less-Addictive Drugs
Inside Health Policy
Health plans and pharmacy benefit managers make it difficult for people to get less-addictive pain killers while making it easier for them to get cheaper, highly-addictive drugs….Read More. -
Oct 18, 2017
Pharmaceutical middle men reforms would save patients and taxpayers billions
The Hill
PBMs, the goliath health insurance middle-men wedged between plan managers, drug manufacturers, patients and pharmacies, make huge profits by forcing pharmacies to pay back a portion of drug sales after the sale has been completed…Read More.
View Archives
By Date
- May 2025 (1)
- April 2025 (2)
- March 2025 (3)
- February 2025 (2)
- January 2025 (2)
- December 2024 (3)
- August 2024 (2)
- July 2024 (3)
- June 2024 (2)
- April 2024 (1)
- March 2024 (4)
- February 2024 (1)
- November 2023 (3)
- October 2023 (1)